Lobbying Information
Subject Matters
- Budget
- Consumer Issues
- Education
- Government Procurement
- Health
- Industry
- Intellectual Property
- Internal Trade
- International Relations
- International Trade
- Science and Technology
- Taxation and Finance
Subject Matter Details
Policies or Program
- Federal/Provincial/Territorial vaccine procurement programs administered by Science and Professional Services Procurement Directorate (SPSPD) of PWGSC with regard to the recommendation and funding of vaccines through Public Health programs by governments in Canada, including issues that relate to the National Immunization Strategy.
- sanofi-aventis Biotalent Challenge program in support of the promotion of biotechnology and science education and innovation in Canada
Communication Techniques
-
Written communication
-
Oral communication
Government Institutions
-
Canadian Institutes of Health Research (CIHR)
-
Canadian International Development Agency (CIDA)
-
Finance Canada (FIN)
-
Foreign Affairs and International Trade Canada (DFAITC)
-
Health Canada (HC)
-
House of Commons
-
Human Resources Development Canada (HRDC)
-
Industry Canada
-
National Research Council (NRC)
-
Patented Medicine Prices Review Board (PMPRB)
-
Prime Minister's Office (PMO)
-
Public Health Agency of Canada (PHAC)
-
Public Works and Government Services Canada
In-house Corporation Details
Description of activities
Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone. Backed by a world-class Research & Development organization, sanofi-aventis is developing leading positions in seven major therapeutic areas: cardiovascular disease, thrombosis, oncology, metabolic diseases, central nervous system, internal medicine, and vaccines. Sanofi Pasteur, the vaccines division of the sanofi-aventis Group, provided more than 1.6 billion doses of vaccine in 2009, making it possible to immunize more than 500 million people across the globe. A world leader in the vaccine industry, Sanofi Pasteur offers the broadest range of vaccines, providing protection against 20 infectious diseases.
Responsible officer name and position during the period of this registration
J .Mark Lievonen,
President
Government funding
End date of the last completed financial year:
2009-12-31
List of Government Funding
|
Government Institution
|
Funding Received in Last Financial Year
|
Funding Expected in Current Financial Year
|
|
Ontario Ministry of Research and Innovation
|
$2,381,463.00
|
Yes
|
In-house Corporation Contact Information
Address:
1755 Steeles Avenue West
Toronto, ON M2R 3T4
Canada
Telephone number:
416-667-2760
Fax number:
416-667-2977
Parent Company Information
- sanofi-aventis
-
174 avenue de France
Paris 75013
France
Subsidiary Beneficiary Information
- Sanofi Pasteur Inc.
-
1 Discovery Drive
Swiftwater, PA 18370
United States of America
Lobbyists Details
Senior Officers whose lobbying activities represent less than 20% of their Duties
- Luis Barreto,
Vice President, Immunization and Scientific Policy |
No public offices held
- J. Mark Lievonen,
President |
No public offices held
- James Tartaglia,
Vice President, New Vaccine Project Head North America |
No public offices held
Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties
- Jason Locklin,
Deputy Director, Government Relations |
No public offices held
- Robert Van Exan,
Director, Immunization Policy |
No public offices held
